Benjamin Drenger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benjamin Drenger has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Dan Gilon
Department of Internal Medicine (Cardiology), Hebrew University of Jerusalem, Jerusalem, Israel
3 shared publicationsYaacov Gozal
From the Departments of Anesthesiology and Critical Care Medicine, Hadassah–Hebrew University Medical Center, Jerusalem, Israel (B.D.); Duke University Medical Center, Durham, NC (M.L.F., J.P.M., S.A.); Ischemia Research and Education Foundation, San Francisco, CA (Y.M., C.D., D.T.M.); and Shaare Zedek Medical Center, Jerusalem, Israel (Y.G.).
3 shared publicationsMordechai Chevion
2 shared publicationsAllan S Jaffe
Department of Medicine/Cardiology, Mayo Clinic, Rochester, MN
1 shared publicationAmir Elami
1 shared publicationCynthia Dietzel
From the Departments of Anesthesiology and Critical Care Medicine, Hadassah–Hebrew University Medical Center, Jerusalem, Israel (B.D.); Duke University Medical Center, Durham, NC (M.L.F., J.P.M., S.A.); Ischemia Research and Education Foundation, San Francisco, CA (Y.M., C.D., D.T.M.); and Shaare Zedek Medical Center, Jerusalem, Israel (Y.G.).
1 shared publication
Latest Publications
- 1 May 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (5) , 1254-1257
Professor Giora Landesberg, MD, DSc, MBA, 1954-2021: A Physician and Research Pioneer in Perioperative Myocardial Infarction
- 1 May 2022
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 36 (5) , 1254-1257
Professor Giora Landesberg, MD, DSc, MBA, 1954-2021: A Physician and Research Pioneer in Perioperative Myocardial Infarction
- 17 July 2012
- Published by Wolters Kluwer Health in Circulation
- Vol. 126 (3) , 261-269
Patterns of Use of Perioperative Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass
Background—: Despite proven benefit in ambulatory patients with ischemic heart disease, the pattern of use of angiotensin-converting enzyme inhibitors (ACEIs) in coronary artery bypass graft surgery has been erratic and controversial. Methods and Results—: This is a prospective observational study of 4224 patients undergoing coronary artery bypass graft surgery. The cohort included 1838 patients receiving ACEI therapy before surgery and 2386 (56.5%) without ACEI exposure. Postoperatively, the pattern of ACEI use yielded 4 groups: continuation, 915 (21.7%); withdrawal, 923 (21.8%); addition, 343 (8.1%); and no ACEI, 2043 (48.4%). Continuous treatment with ACEI versus no ACEI was associated with substantive reductions of risk of nonfatal events (adjusted odds ratio for the composite outcome, 0.69; 95% confidence interval, 0.52–0.91; P =0.009) and a cardiovascular event (odds ratio, 0.64; 95% confidence interval, 0.46–0.88; P =0.006). Addition of ACEI de novo postoperatively compared with no ACEI therapy was also associated with a significant reduction of risk of composite outcome (odds ratio, 0.56; 95% confidence interval, 0.38–0.84; P =0.004) and a cardiovascular event (odds ratio, 0.63; 95% confidence interval, 0.40–0.97; P =0.04). On the other hand, continuous treatment of ACEI versus withdrawal of ACEI was associated with decreased risk of the composite outcome (odds ratio, 0.50; 95% confidence interval, 0.38–0.66; P P P =0.005, respectively). No differences in in-hospital mortality and cerebral events were noted. Conclusions—: Our study suggests that withdrawal of ACEI treatment after coronary artery bypass graft surgery is associated with nonfatal in-hospital ischemic events. Furthermore, continuation of ACEI or de novo ACEI therapy early after cardiac surgery is associated with improved in-hospital outcomes.
- 17 July 2012
- Published by Wolters Kluwer Health in Circulation
- Vol. 126 (3) , 261-269
Patterns of Use of Perioperative Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass
Background—: Despite proven benefit in ambulatory patients with ischemic heart disease, the pattern of use of angiotensin-converting enzyme inhibitors (ACEIs) in coronary artery bypass graft surgery has been erratic and controversial. Methods and Results—: This is a prospective observational study of 4224 patients undergoing coronary artery bypass graft surgery. The cohort included 1838 patients receiving ACEI therapy before surgery and 2386 (56.5%) without ACEI exposure. Postoperatively, the pattern of ACEI use yielded 4 groups: continuation, 915 (21.7%); withdrawal, 923 (21.8%); addition, 343 (8.1%); and no ACEI, 2043 (48.4%). Continuous treatment with ACEI versus no ACEI was associated with substantive reductions of risk of nonfatal events (adjusted odds ratio for the composite outcome, 0.69; 95% confidence interval, 0.52–0.91; P =0.009) and a cardiovascular event (odds ratio, 0.64; 95% confidence interval, 0.46–0.88; P =0.006). Addition of ACEI de novo postoperatively compared with no ACEI therapy was also associated with a significant reduction of risk of composite outcome (odds ratio, 0.56; 95% confidence interval, 0.38–0.84; P =0.004) and a cardiovascular event (odds ratio, 0.63; 95% confidence interval, 0.40–0.97; P =0.04). On the other hand, continuous treatment of ACEI versus withdrawal of ACEI was associated with decreased risk of the composite outcome (odds ratio, 0.50; 95% confidence interval, 0.38–0.66; P P P =0.005, respectively). No differences in in-hospital mortality and cerebral events were noted. Conclusions—: Our study suggests that withdrawal of ACEI treatment after coronary artery bypass graft surgery is associated with nonfatal in-hospital ischemic events. Furthermore, continuation of ACEI or de novo ACEI therapy early after cardiac surgery is associated with improved in-hospital outcomes.
- 1 February 2012
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 116 (2) , 489-490
In Reply
I have read with great interest the comments of Drs. Liu and Xia. Their study on a similar model of streptozotocine-induced diabetic rats1 confirmed my findings that myocardial signal transducer and activator of transcription 3 (STAT3) concentrations are significantly decreased in the diabetic heart, whereas normal STAT3 concentrations are essential for initiation of the protective process of sevoflurane postconditioning (postC) in diabetes. They also described their findings that STAT3 concentrations might recover in diabetic hearts in the presence of N -acetylcysteine. They suggest that N -acetylcysteine and allupurinol promote tolerance of the myocardium to ischemic injury by restoring adinopectin concentration, and thus, they propose that N -acetylcysteine might be effective in restoring sevoflurane postC in the diabetic heart.
- 1 February 2012
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 116 (2) , 489-490
In Reply
I have read with great interest the comments of Drs. Liu and Xia. Their study on a similar model of streptozotocine-induced diabetic rats1 confirmed my findings that myocardial signal transducer and activator of transcription 3 (STAT3) concentrations are significantly decreased in the diabetic heart, whereas normal STAT3 concentrations are essential for initiation of the protective process of sevoflurane postconditioning (postC) in diabetes. They also described their findings that STAT3 concentrations might recover in diabetic hearts in the presence of N -acetylcysteine. They suggest that N -acetylcysteine and allupurinol promote tolerance of the myocardium to ischemic injury by restoring adinopectin concentration, and thus, they propose that N -acetylcysteine might be effective in restoring sevoflurane postC in the diabetic heart.
- 1 June 2011
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 114 (6) , 1364-1372
Diabetes Blockade of Sevoflurane Postconditioning Is Not Restored by Insulin in the Rat Heart
Background: The possibility of restoring sevoflurane postconditioning (sevo-postC) cardioprotection in diabetic animals is uncertain. We hypothesized that attenuation of myocardial injury by sevo-postC might be hindered by inhibition of signal transducer and activator of transcription (STAT) 3-regulated activity of phosphatidylinositol 3-kinase (PI3K) in diabetic animals. To determine whether postC cardioprotection can be restored by normoglycemia, we treated rats with insulin. Methods: Diabetic or nondiabetic rats were randomly subjected to 30-min ischemia/reperfusion, with ischemic postC or sevo-postC, with and without mitochondrial adenosine triphosphate-dependent potassium channel blocker 5-hydroxy decanoate sodium and PI3K antagonist wortmannin. The infarct area, phosphorylated STAT3, and apoptosis were examined. Studies were repeated after insulin treatment. Results: Ischemic postC and sevo-postC significantly reduced infarct size by 50% in the nondiabetic rats (P < 0.002), a phenomenon completely reversed by 5-hydroxy decanoate sodium and wortmannin. Diabetes mellitus blocked the protective effect of postC, and insulin treatment to achieve normoglycemia did not restore cardioprotection. Phosphorylated STAT3 nuclear retention was significantly increased after ischemia-reperfusion and was further enhanced in response to ischemic postC (P < 0.05) but was significantly reduced in diabetic rats (by 43%; P < 0.01). Conclusions: The effective reduction in infarct size and apoptosis in the nondiabetic rat heart by postC was completely abrogated in diabetic rats. This inhibition is not relieved by insulin-induced normoglycemia. The PI3K pathway and mitochondrial adenosine triphosphate-dependent potassium channel activation are involved in the mechanism of postC. In diabetic rats, STAT3 activation was strongly reduced, as was postC cardioprotection, suggesting that the inability of insulin to restore postC may be attributed to diabetes-induced STAT3-mediated inhibition of PI3K signaling.
- 1 June 2011
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 114 (6) , 1364-1372
Diabetes Blockade of Sevoflurane Postconditioning Is Not Restored by Insulin in the Rat Heart
Background: The possibility of restoring sevoflurane postconditioning (sevo-postC) cardioprotection in diabetic animals is uncertain. We hypothesized that attenuation of myocardial injury by sevo-postC might be hindered by inhibition of signal transducer and activator of transcription (STAT) 3-regulated activity of phosphatidylinositol 3-kinase (PI3K) in diabetic animals. To determine whether postC cardioprotection can be restored by normoglycemia, we treated rats with insulin. Methods: Diabetic or nondiabetic rats were randomly subjected to 30-min ischemia/reperfusion, with ischemic postC or sevo-postC, with and without mitochondrial adenosine triphosphate-dependent potassium channel blocker 5-hydroxy decanoate sodium and PI3K antagonist wortmannin. The infarct area, phosphorylated STAT3, and apoptosis were examined. Studies were repeated after insulin treatment. Results: Ischemic postC and sevo-postC significantly reduced infarct size by 50% in the nondiabetic rats (P < 0.002), a phenomenon completely reversed by 5-hydroxy decanoate sodium and wortmannin. Diabetes mellitus blocked the protective effect of postC, and insulin treatment to achieve normoglycemia did not restore cardioprotection. Phosphorylated STAT3 nuclear retention was significantly increased after ischemia-reperfusion and was further enhanced in response to ischemic postC (P < 0.05) but was significantly reduced in diabetic rats (by 43%; P < 0.01). Conclusions: The effective reduction in infarct size and apoptosis in the nondiabetic rat heart by postC was completely abrogated in diabetic rats. This inhibition is not relieved by insulin-induced normoglycemia. The PI3K pathway and mitochondrial adenosine triphosphate-dependent potassium channel activation are involved in the mechanism of postC. In diabetic rats, STAT3 activation was strongly reduced, as was postC cardioprotection, suggesting that the inability of insulin to restore postC may be attributed to diabetes-induced STAT3-mediated inhibition of PI3K signaling.
- 1 April 2010
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 24 (2) , 348-355
Potential Role for Coronary Computerized Angiography for Assessing Preoperative Ischemic Risk
- 1 April 2010
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 24 (2) , 348-355
Potential Role for Coronary Computerized Angiography for Assessing Preoperative Ischemic Risk
- 1 June 2008
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 22 (3) , 369-376
Myocardial Metabolism Altered by Ischemic Preconditioning and Enflurane in Off-Pump Coronary Artery Surgery
- 1 June 2008
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 22 (3) , 369-376
Myocardial Metabolism Altered by Ischemic Preconditioning and Enflurane in Off-Pump Coronary Artery Surgery
- 1 September 2002
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 96 (Sup 2) , A629
KATP Channels Mediate the Effect of Ischemic Preconditioning on Free Radical Production in a Rabbit Heart Model
- 1 September 2002
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 96 (Sup 2) , A629
KATP Channels Mediate the Effect of Ischemic Preconditioning on Free Radical Production in a Rabbit Heart Model
- 1 July 1999
- Vol. 2 (2) , 16-21
Halothane modifies oxygen free radical activity on the voltage-sensitive calcium channels in canine myocardial membranes.
The functional derangements in the myocyte cell membrane, the sarcolemma, during short myocardial ischaemia and reperfusion are attributed to excessive influx of Ca2+ ions via the voltage-sensitive calcium channels (VSCC) and to the free radical-related injury. However, it is unclear whether the primary changes in the VSCC should be attributed to the ischaemic effect or to free radical action on channel constituents. Under these circumstances of ischaemia and reperfusion, volatile anaesthetics have exhibited protective properties on the myocardium. The present study is aimed at characterizing the effect of artificially-generated oxygen free radicals on the VSCC in canine sarcolemma, independently of the effect of ischaemia, and the effect of halothane on the membranes during the surge of the free radicals. Selective production of free radicals (O2-, CO2-) was made by gamma irradiation of isolated sarcolemma membranes with 137 Cesium (Cs), in the presence of 20 mM sodium formate. Control studies were performed without formate in the aqueous solution. In an additional group, liquid halothane (3 microl. 1.9 vol%) was added to the sarcolemma / formate preparation immediately prior to irradiation. The effects of free radicals on the VSCC was evaluated by redioligand binding studies of the calcium channel blocker [3H] isradipine to the sarcolemma. In six control studies, the rediolytic aqueous species produced by 137 Cs irradiation resulted in unchanged [3 H] isradipine binding. In the presence of formate [n=9], the free radicals have caused a 23% to 25% decrease, both, in density and dissociation constant (P=0.05) of [3 H]isradipine to the VSCC binding sites. When superoxide radicals were generated in the presence of 1.9% halothane and formate (n=6), a significant increase in maximal binding capacity (by 55% +/- 2; P<0.01) and in the dissociation constant (by 209% +/- 35, P<0.01) occurred. Oxidative free radicals which are generated by gamma irradiation exerted minimal changes on the normal function of the VSCC as reflected by the non-significant changes in [3 H] isradipine specific binding. Introduction of halothane into free radical generating system causes acute perturbations to the VSCC kinetics, and does not provide protection to the cardiac membranes.
- 1 July 1999
- Vol. 2 (2) , 16-21
Halothane modifies oxygen free radical activity on the voltage-sensitive calcium channels in canine myocardial membranes.
The functional derangements in the myocyte cell membrane, the sarcolemma, during short myocardial ischaemia and reperfusion are attributed to excessive influx of Ca2+ ions via the voltage-sensitive calcium channels (VSCC) and to the free radical-related injury. However, it is unclear whether the primary changes in the VSCC should be attributed to the ischaemic effect or to free radical action on channel constituents. Under these circumstances of ischaemia and reperfusion, volatile anaesthetics have exhibited protective properties on the myocardium. The present study is aimed at characterizing the effect of artificially-generated oxygen free radicals on the VSCC in canine sarcolemma, independently of the effect of ischaemia, and the effect of halothane on the membranes during the surge of the free radicals. Selective production of free radicals (O2-, CO2-) was made by gamma irradiation of isolated sarcolemma membranes with 137 Cesium (Cs), in the presence of 20 mM sodium formate. Control studies were performed without formate in the aqueous solution. In an additional group, liquid halothane (3 microl. 1.9 vol%) was added to the sarcolemma / formate preparation immediately prior to irradiation. The effects of free radicals on the VSCC was evaluated by redioligand binding studies of the calcium channel blocker [3H] isradipine to the sarcolemma. In six control studies, the rediolytic aqueous species produced by 137 Cs irradiation resulted in unchanged [3 H] isradipine binding. In the presence of formate [n=9], the free radicals have caused a 23% to 25% decrease, both, in density and dissociation constant (P=0.05) of [3 H]isradipine to the VSCC binding sites. When superoxide radicals were generated in the presence of 1.9% halothane and formate (n=6), a significant increase in maximal binding capacity (by 55% +/- 2; P<0.01) and in the dissociation constant (by 209% +/- 35, P<0.01) occurred. Oxidative free radicals which are generated by gamma irradiation exerted minimal changes on the normal function of the VSCC as reflected by the non-significant changes in [3 H] isradipine specific binding. Introduction of halothane into free radical generating system causes acute perturbations to the VSCC kinetics, and does not provide protection to the cardiac membranes.